Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global recombinant DNA technology market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.

Recombinant DNA Technology Market Trends:

The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, component, application and end user.

Breakup by Product:

  • Medical
    • Therapeutic Agent
    • Human Protein
    • Vaccines
  • Non-Medical
    • Biotech Crops
    • Specialty Chemicals
    • Others
       

Breakup by Component:

  • Expression System
  • Cloning Vector
     

Breakup by Application:

  • Food and Agriculture
  • Health and Disease
  • Environment
  • Others
     

Breakup by End User:

  • Biotechnology and Pharmaceutical Companies
  • Academic and Government Research Institutes
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Component, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global recombinant DNA technology market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global recombinant DNA technology market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Recombinant DNA Technology Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Medical
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Therapeutic Agent
           6.1.2.2 Human Protein
           6.1.2.3 Vaccines
        6.1.3 Market Forecast
    6.2    Non-Medical
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Biotech Crops
           6.2.2.2 Specialty Chemicals
           6.2.2.3 Others
        6.2.3 Market Forecast
7    Market Breakup by Component
    7.1    Expression System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cloning Vector
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Application
    8.1    Food and Agriculture
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Health and Disease
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Environment
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by End User
    9.1    Biotechnology and Pharmaceutical Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Academic and Government Research Institutes
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Amgen Inc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Cibus
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    F.Hoffmann-La Roche Ltd
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 SWOT Analysis
        15.3.4    GenScript
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    GlaxoSmithKline plc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Horizon Discovery Group plc
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    Merck KGaA
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    New England Biolabs
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Novo Nordisk A/S
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi S.A
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Syngene International Ltd (Biocon Limited)
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2020
Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2020
Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2020
Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2020
Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2020
Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2020
Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2021-2026
Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
Table 8: Global: Recombinant DNA Technology Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links